102 related articles for article (PubMed ID: 3307576)
1. The place of prostacyclin in the clinical management of primary pulmonary hypertension.
Higenbottam T
Am Rev Respir Dis; 1987 Sep; 136(3):782-5. PubMed ID: 3307576
[TBL] [Abstract][Full Text] [Related]
2. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
3. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
McLaughlin VV; Genthner DE; Panella MM; Rich S
N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
[TBL] [Abstract][Full Text] [Related]
4. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.
Aguilar RV; Farber HW
Am J Respir Crit Care Med; 2000 Nov; 162(5):1846-50. PubMed ID: 11069824
[TBL] [Abstract][Full Text] [Related]
5. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.
Conte JV; Gaine SP; Orens JB; Harris T; Rubin LJ
J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232
[TBL] [Abstract][Full Text] [Related]
6. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
Saji T; Nakayama T; Ishikita T; Matsuura H
Nihon Rinsho; 2001 Jun; 59(6):1132-8. PubMed ID: 11411125
[TBL] [Abstract][Full Text] [Related]
7. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).
Jones DK; Higenbottam TW; Wallwork J
Br Heart J; 1987 Mar; 57(3):270-8. PubMed ID: 3552006
[TBL] [Abstract][Full Text] [Related]
9. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
10. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
[TBL] [Abstract][Full Text] [Related]
11. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
Montalescot G; Drobinski G; Meurin P; Maclouf J; Sotirov I; Philippe F; Choussat R; Morin E; Thomas D
Am J Cardiol; 1998 Sep; 82(6):749-55. PubMed ID: 9761085
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
Friedman R; Mears JG; Barst RJ
Circulation; 1997 Nov; 96(9):2782-4. PubMed ID: 9386137
[TBL] [Abstract][Full Text] [Related]
14. The role of prostacyclin in the treatment of primary pulmonary hypertension: the Cambridge experience.
Cremona G
Cardiologia; 1993 Dec; 38(12 Suppl 1):227-32. PubMed ID: 8020021
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
Groves BM; Rubin LJ; Frosolono MF; Cato AE; Reeves JT
Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator therapy for primary pulmonary hypertension in children.
Barst RJ; Maislin G; Fishman AP
Circulation; 1999 Mar; 99(9):1197-208. PubMed ID: 10069788
[TBL] [Abstract][Full Text] [Related]
17. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin in the management of pulmonary hypertension after heart transplantation.
Pascual JM; Fiorelli AI; Bellotti GM; Stolf NA; Jatene AD
J Heart Transplant; 1990; 9(6):644-51. PubMed ID: 2277302
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of primary pulmonary arterial hypertension: current status].
Solèr M
Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
[TBL] [Abstract][Full Text] [Related]
20. [The possible clinical role of the cardiac pulmonary power in patients with primary pulmonary hypertension. Initial observations].
Herrera EL; Zárate JS; Valenzuela EC; Carrillo A
Arch Cardiol Mex; 2006; 76(2):140-50. PubMed ID: 16859210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
